MYTIDE THERAPEUTICS, INC.

Profile

Company Names

MYTIDE THERAPEUTICS, INC.

Addresses

451 D STREET SUITE 707, BOSTON, MA 02210

Phone Numbers

(207) 659-4206

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$8,231,824.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-12-23 
$1,164,111.00 
$2,500,000.00 
$1,335,889.00 
Equity 
1
2021-12-30 
$7,067,713.00 
$7,067,713.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERRIK 
 
ANDERSON 
DIRECTOR
AVITIDE, INC.   |  KAIROS BIOLOGICS FOUNDATION LLC   |  GREEN D FOUNDERS FUND 2014-I, LLLP   |  COMPASS THERAPEUTICS LLC   |  GTP AW FUND II, LLC   |  UDH MSPV I LLC   |  UDH MSPV II LLC   |  VERNAL BIOSCIENCES, INC.   |  WHEELER BIO, INC.   |  MYTIDE THERAPEUTICS, INC.   |  CANTAI THERAPEUTICS, INC.   |  ALUMNI VENTURES GROUP LLC   |  AAKHA BIOLOGICS, INC.   |  ANGIEX, INC.   |  82VS SEED FUND, LP
JASON 
 
NORRIS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NEW VALENCE ROBOTICS CORP   |  DIGITAL ALLOYS INC   |  MYTIDE THERAPEUTICS, INC.   |  ELEKTROFI, INC.   |  LAPIX THERAPEUTICS INC.   |  ALKALINTH INC.
DALE 
 
THOMAS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BEST ENERGY, LLC   |  MYTIDE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-01-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-23 
2022-06-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-30 
2022-01-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#